Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
ERCO Pharma AB
AB
Active
Org 5569811887
Nybrogatan 17, 114 39
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2014 · 11 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ERCO Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
-1M
-1M
-1M
2021: 0M
0M
2021
2022: -1M
-1M
2022
2023: 0M (+100% vs 2022)
0M
2023
2024: 0M
0M
2024
2025: not reported
2025
EBITDA
SEK millions
0M
-2M
-3M
-5M
-6M
2021: -3M
-3M
2021
2022: -5M (-67% vs 2021)
-5M
-67%
2022
2023: -3M (+40% vs 2022)
-3M
+40%
2023
2024: 0M (+100% vs 2023)
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
—
1
−416
−524
0
Staff expenses
−46
−44
−1 385
−1 721
—
EBITDA
−63
−94
−2 983
−4 932
−3 175
Depreciation & amort.
—
—
−37
−37
−222
EBIT
−63
−94
−3 020
−4 970
−3 397
Net financials
0
−0
0
0
—
Profit before tax
−63
−94
−3 020
0
4
Tax
—
—
—
−0
−1
Net profit
−63
−94
−3 020
0
3
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
98
81
111
1 150
267
Equity
91
71
55
52
52
Long-term debt
—
—
—
—
0
Short-term debt
7
10
56
1 098
215
Total debt
7
10
56
1 098
215
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
93,1 %
This company
38,2 %
Market median
This company
Market median
144% above market
2021
2025
Return on equity
−68,5 %
This company
18,4 %
Market median
This company
Market median
472% below market
2021
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
0,07×
This company
0,62×
Market median
This company
Market median
89% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on ERCO Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
